The forecast data from 2024 to 2028 indicates that hospital discharges for malignant neoplasm of the trachea, bronchus, and lung in France are expected to remain stable, with a consistent rate of 66.3 discharges per hundred thousand persons. In 2023, this rate was 66.3 as well, indicating no expected year-on-year variation over this period. Over the projected five-year span, the compound annual growth rate (CAGR) remains at 0%, further emphasizing stability in discharge rates.
Trends to watch for in the future include advancements in medical treatments, changes in smoking rates, and improvements in early detection which could impact the discharge rates. Moreover, shifts in healthcare policy and resource allocation might also influence these projections.
